Guidepost in Motion: Off The Chain Part 2 Innovations and Best Practices in Crypto and Blockchain
Cyberside Chats: Don’t silo your risk from legal (with Ingrid Rodriguez)
Digging Deeper Episode 10: Misguided or Misconduct? Understanding Bad Behavior in the Corporate World
M365 in 5 – Part 7: Teams Audio/Video (A/V) Conferencing
M365 in 5 – Part 6: Teams Channels – The virtual collaboration workspace
M365 in 5 – Part 5: Teams Chats – Modern communications
M365 in 5 – Part 4: Teams – An introduction to collaboration
M365 in 5 – Part 3: OneDrive for Business – Protected personal collaboration
M365 in 5 – Part 2: SharePoint Online – The new file-share environment
M365 in 5 – Part 1: Exchange Online – Not just a mailbox
Sitting with the C-Suite: Differentiating Through Client Service
Sitting with the C-Suite: Culture Integration in a Remote Work Environment
Sitting with the C-Suite: HaystackID and NightOwl Merger Overview
Sitting with the C-Suite: Managing through Challenging Times? Focus on the Key Three
Nota Bene Episode 91: China Q3 Check In - Trade Wars, GDP Growth, Pandemic Comparatives, and Hong Kong with Michael Zhang
Sitting with the C-Suite: COVID 19 Impact – Four Sectors of Change for the Legal Industry
Sitting with the C-Suite: Legal Industry Technology Adoption
Sitting with the C-Suite: Trial Prep as a Launchpad for Services
Sitting with the C-Suite: eDiscovery Observations – Historical Lookback to 1990s and 2000s
Sitting with the C-Suite: Servient – What’s Next
Cross-jurisdiction cooperation in the fight against international corruption and bribery is intensifying. The UK’s Serious Fraud Office (SFO), France’s National Financial Prosecutor’s Office (PNF), and Switzerland’s Office of...more
Compliance professionals are riding high. They are the darlings of the corporate governance world, commanding higher salaries, C-Suite positions with access to senior leadership and the board, and an empowered position within...more
Any company doing business in China has to wonder whether they might find themselves in the unwelcome spotlight recently turned on certain participants in China’s pharmaceutical market....more